Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To follow up IP status of APIs in the Commonwealth of Independent States
— API wholesaler, UK
To update my knowledge in several markets
— Marketing professional, Spain
To obtain the latest patent expiry data
— Pharmaceutical company sales director, Pakistan
To understand patent expirations of controlled substances
— Consulting, USA
To get reliable data on drug patent information
— CFO, Pharmaceuticals, Singapore
Generated: May 24, 2017
| Tradename: | 1 |
| Applicant: | 1 |
| Ingredient: | 1 |
| Patents: | 1 |
| Therapeutic Class: | Antidotes, Deterrents, and Toxicologic Agents |
| Formulation / Manufacturing: | see details |
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
NICODERM CQ |
nicotine |
FILM, EXTENDED RELEASE;TRANSDERMAL | 020165 | NDA | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | 0135-0145 | 0135-0145-02 | 14 PATCH in 1 CARTON (0135-0145-02) > 24 h in 1 PATCH |
NICODERM CQ |
nicotine |
FILM, EXTENDED RELEASE;TRANSDERMAL | 020165 | NDA | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | 0135-0194 | 0135-0194-01 | 7 PATCH in 1 CARTON (0135-0194-01) > 24 h in 1 PATCH |
| Active Rx/OTC/Discontinued: | OTC | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 21MG/24HR | ||||
| Approval Date: | Aug 2, 1996 | TE: | RLD: | Yes | |||||
| Patent: | 8,075,911 | Patent Expiration: | May 22, 2021 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | 8,663,680 | Patent Expiration: | Feb 13, 2020 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | 9,205,059 | Patent Expiration: | Dec 15, 2019 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | NICODERM CQ | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020165-005 | Aug 2, 1996 | 5,004,610 | ► Subscribe | ||||||||||||||||||||||
Sanofi Aventis Us | NICODERM CQ | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020165-006 | Aug 2, 1996 | 5,633,008 | ► Subscribe | ||||||||||||||||||||||
Sanofi Aventis Us | NICODERM CQ | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020165-004 | Aug 2, 1996 | 5,633,008 | ► Subscribe | ||||||||||||||||||||||
Sanofi Aventis Us | NICODERM CQ | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020165-006 | Aug 2, 1996 | 5,344,656 | ► Subscribe | ||||||||||||||||||||||
Sanofi Aventis Us | NICODERM CQ | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020165-005 | Aug 2, 1996 | 5,633,008 | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To have a global perspective of drug product patents
— Generic drug product company R&D manager, Spain
To do IP due diligence for investment decisions
— Investment manager, South Korea
For information about active patents for the development of new OTC products
— Pharmaceutical consultant, France
To identify producers of specific APIs
— Market research, Germany
To identify possible time generic approval and launch
— Formulation research, South Korea
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
